mouse anti arginase 1 Search Results


human/mouse/rat arginase 1/arg1 antibody  (Bio-Techne corporation)
94
Bio-Techne corporation human/mouse/rat arginase 1/arg1 antibody
Human/Mouse/Rat Arginase 1/Arg1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human/mouse/rat arginase 1/arg1 antibody/product/Bio-Techne corporation
Average 94 stars, based on 1 article reviews
human/mouse/rat arginase 1/arg1 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
rabbit anti-mouse arginase 1  (Becton Dickinson)
90
Becton Dickinson rabbit anti-mouse arginase 1
Rabbit Anti Mouse Arginase 1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse arginase 1/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
rabbit anti-mouse arginase 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-mouse arginase 1  (Abbexa Ltd)
90
Abbexa Ltd anti-mouse arginase 1
Pharmacological Inhibition of ABCA1 Enhances the Inflammatory Polarization of TAMs In Vivo (A) : Quantification of ABCA1 expression in cholesterol-treated BMDMs ex vivo. BMDMs were treated with the indicated concentrations of cholesterol for 24 h. Cells were harvested and FCM was performed to identify the expression level of ABCA1 (n = 3). (B, C) : Quantification of ABCA1 expression (B) and CD86 and CD206 expression (C) in lovastatin-treated TAMs ex vivo. TAMs were treated with the indicated concentrations of lovastatin for 24 h. FCM was performed to identify these molecular expressions. (D) : Experimental setup of lovastatin-treated murine IDH WT GBM model. Eight mice per group. (E, F) : Representative flow cytometry plots (E) and quantification of ABCA1 expression levels in TAMs (F) . (G–J) : Representative flow cytometry plots (G) and quantification of TAM functional polarization (H–J) . <t>ARG1</t> (H) were identified as anti-inflammatory macrophage markers; IFN-γ (I) and TNF-α (J) were identified as inflammatory macrophage markers. (K–M) : Experimental setup (K) and tumor growth and survival monitoring (L, M) of lovastatin-treated murine GL261 IDH-WT-Luc model. Eight mice per group. The difference between risk groups was calculated by the Mann–Whitney test and log-rank test (NS, no statistical significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
Anti Mouse Arginase 1, supplied by Abbexa Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-mouse arginase 1/product/Abbexa Ltd
Average 90 stars, based on 1 article reviews
anti-mouse arginase 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
mouse anti arginase-1  (Cayman Chemical)
90
Cayman Chemical mouse anti arginase-1
Pharmacological Inhibition of ABCA1 Enhances the Inflammatory Polarization of TAMs In Vivo (A) : Quantification of ABCA1 expression in cholesterol-treated BMDMs ex vivo. BMDMs were treated with the indicated concentrations of cholesterol for 24 h. Cells were harvested and FCM was performed to identify the expression level of ABCA1 (n = 3). (B, C) : Quantification of ABCA1 expression (B) and CD86 and CD206 expression (C) in lovastatin-treated TAMs ex vivo. TAMs were treated with the indicated concentrations of lovastatin for 24 h. FCM was performed to identify these molecular expressions. (D) : Experimental setup of lovastatin-treated murine IDH WT GBM model. Eight mice per group. (E, F) : Representative flow cytometry plots (E) and quantification of ABCA1 expression levels in TAMs (F) . (G–J) : Representative flow cytometry plots (G) and quantification of TAM functional polarization (H–J) . <t>ARG1</t> (H) were identified as anti-inflammatory macrophage markers; IFN-γ (I) and TNF-α (J) were identified as inflammatory macrophage markers. (K–M) : Experimental setup (K) and tumor growth and survival monitoring (L, M) of lovastatin-treated murine GL261 IDH-WT-Luc model. Eight mice per group. The difference between risk groups was calculated by the Mann–Whitney test and log-rank test (NS, no statistical significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
Mouse Anti Arginase 1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti arginase-1/product/Cayman Chemical
Average 90 stars, based on 1 article reviews
mouse anti arginase-1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Pharmacological Inhibition of ABCA1 Enhances the Inflammatory Polarization of TAMs In Vivo (A) : Quantification of ABCA1 expression in cholesterol-treated BMDMs ex vivo. BMDMs were treated with the indicated concentrations of cholesterol for 24 h. Cells were harvested and FCM was performed to identify the expression level of ABCA1 (n = 3). (B, C) : Quantification of ABCA1 expression (B) and CD86 and CD206 expression (C) in lovastatin-treated TAMs ex vivo. TAMs were treated with the indicated concentrations of lovastatin for 24 h. FCM was performed to identify these molecular expressions. (D) : Experimental setup of lovastatin-treated murine IDH WT GBM model. Eight mice per group. (E, F) : Representative flow cytometry plots (E) and quantification of ABCA1 expression levels in TAMs (F) . (G–J) : Representative flow cytometry plots (G) and quantification of TAM functional polarization (H–J) . ARG1 (H) were identified as anti-inflammatory macrophage markers; IFN-γ (I) and TNF-α (J) were identified as inflammatory macrophage markers. (K–M) : Experimental setup (K) and tumor growth and survival monitoring (L, M) of lovastatin-treated murine GL261 IDH-WT-Luc model. Eight mice per group. The difference between risk groups was calculated by the Mann–Whitney test and log-rank test (NS, no statistical significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

Journal: Frontiers in Immunology

Article Title: Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDH WT glioblastoma

doi: 10.3389/fimmu.2022.869061

Figure Lengend Snippet: Pharmacological Inhibition of ABCA1 Enhances the Inflammatory Polarization of TAMs In Vivo (A) : Quantification of ABCA1 expression in cholesterol-treated BMDMs ex vivo. BMDMs were treated with the indicated concentrations of cholesterol for 24 h. Cells were harvested and FCM was performed to identify the expression level of ABCA1 (n = 3). (B, C) : Quantification of ABCA1 expression (B) and CD86 and CD206 expression (C) in lovastatin-treated TAMs ex vivo. TAMs were treated with the indicated concentrations of lovastatin for 24 h. FCM was performed to identify these molecular expressions. (D) : Experimental setup of lovastatin-treated murine IDH WT GBM model. Eight mice per group. (E, F) : Representative flow cytometry plots (E) and quantification of ABCA1 expression levels in TAMs (F) . (G–J) : Representative flow cytometry plots (G) and quantification of TAM functional polarization (H–J) . ARG1 (H) were identified as anti-inflammatory macrophage markers; IFN-γ (I) and TNF-α (J) were identified as inflammatory macrophage markers. (K–M) : Experimental setup (K) and tumor growth and survival monitoring (L, M) of lovastatin-treated murine GL261 IDH-WT-Luc model. Eight mice per group. The difference between risk groups was calculated by the Mann–Whitney test and log-rank test (NS, no statistical significance, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

Article Snippet: Dissociated cells were further incubated with the following antibodies: anti-mouse CD16/CD32 (Multi Sciences, clone 2.4G2, Cat No. AM016-100), IgG2a, κ isotype ctrl (Biolegend, clone MOPC-173, Cat No. 400233), anti-mouse ABCA1 (BIO-RAD, clone 5A1-1422, Cat No. MCA2681), anti-mouse F4/80 (Biolegend, clone BM8, Cat No. 123110), anti-mouse\human CD11b CM1/70, Cat No. 101229), anti-mouse CD86 (Biolegend, clone GL-1, Cat No. 105005), anti-mouse CD206 (Biolegend, clone C068C2, Cat No. 141715), anti-mouse TNF-α (Biolegend, clone MP6-XT22, Cat No. 506303), anti-mouse IFN-γ (Biolegend, clone XMG1.2, Cat No. 506303), anti-mouse Arginase 1 (Abbexa, Polyclonal, Cat No. abx319179), and anti-mouse CD45 (Biolegend, clone 30-F11, Cat No. 103112).

Techniques: Inhibition, In Vivo, Expressing, Ex Vivo, Flow Cytometry, Functional Assay, MANN-WHITNEY